Latest filing published 14 Feb 2018 for Sucampo Pharmaceuticals, Inc.. Read the official filing
This profile gathers the share dealings of Ryuji Ueno in Sucampo Pharmaceuticals, Inc. We count 5 filings; the first trade dates from 19 December 2016 and the latest from 13 February 2018.
No open-market purchase appears, only 1 sale worth €10.0M.
On 14 February 2018 came the latest disclosure, a transaction in Sucampo Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 10 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations